This tool tracks national and state data on two types of medications used to treat opioid use disorder (buprenorphine and naltrexone) and one medication used to treat opioid overdoses (naloxone). 

Brief presenting a neutral and general picture of the debate around single-payer plans, as well as a list of pros and cons.

This analysis provides information on some of the consequences should a case pending before the US Court of Appeals for the 5th Circuit be decided in favor of the plaintiffs. We estimate the state-by-state implications of full ACA repeal for insurance coverage and government funding of health care in 2019.

This brief is an update of a 2017 analysis examining the characteristics of ACA marketplace rating regions with one or two participating insurers. 

Recent study found that changes in specific types of health care spending affected Medicare, Medicaid, and private insurers differently.